HK26584A - Injection solutions containing micelle-forming agents - Google Patents

Injection solutions containing micelle-forming agents

Info

Publication number
HK26584A
HK26584A HK265/84A HK26584A HK26584A HK 26584 A HK26584 A HK 26584A HK 265/84 A HK265/84 A HK 265/84A HK 26584 A HK26584 A HK 26584A HK 26584 A HK26584 A HK 26584A
Authority
HK
Hong Kong
Prior art keywords
solutions containing
forming agents
injection solutions
containing micelle
micelle
Prior art date
Application number
HK265/84A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT511176A external-priority patent/AT352881B/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK26584A publication Critical patent/HK26584A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK265/84A 1976-07-12 1984-03-22 Injection solutions containing micelle-forming agents HK26584A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT511176A AT352881B (de) 1976-07-12 1976-07-12 Verfahren zur herstellung von injektions- loesungen
CH699477A CH628811A5 (en) 1976-07-12 1977-06-07 Injection solutions

Publications (1)

Publication Number Publication Date
HK26584A true HK26584A (en) 1984-03-30

Family

ID=25601846

Family Applications (1)

Application Number Title Priority Date Filing Date
HK265/84A HK26584A (en) 1976-07-12 1984-03-22 Injection solutions containing micelle-forming agents

Country Status (18)

Country Link
US (1) US4158707A (da)
JP (1) JPS6051448B2 (da)
AU (1) AU517249B2 (da)
CA (1) CA1082596A (da)
DE (1) DE2730570A1 (da)
DK (1) DK149483C (da)
FR (2) FR2358161A1 (da)
GB (1) GB1587076A (da)
HK (1) HK26584A (da)
IE (1) IE46037B1 (da)
IL (1) IL52458A (da)
IT (1) IT1202370B (da)
LU (2) LU77708A1 (da)
MY (1) MY8500263A (da)
NL (1) NL189072C (da)
NZ (1) NZ184564A (da)
PH (1) PH16333A (da)
SE (1) SE448516B (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
JPS57163313A (en) * 1981-03-31 1982-10-07 Nippon Shinyaku Co Ltd Vitamin e pharmaceutical and its preparation
JPH0768117B2 (ja) * 1983-05-06 1995-07-26 ベスター・インコーポレイテツド 薬剤放出調整用小胞製剤
US4649155A (en) * 1983-07-22 1987-03-10 Hoffmann-La Roche Inc. Injectable solutions
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
CA1264162A (en) * 1984-03-15 1990-01-02 Manfred Breuninger Glycerol ether phosphatides
US5002936A (en) * 1985-04-12 1991-03-26 Seymour Lieberman Lipophilic complexes of pharmacologically active inorganic mineral acid esters of organic compounds
US4831018A (en) * 1985-05-17 1989-05-16 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
AT388499B (de) * 1985-08-02 1989-06-26 Merz & Co Gmbh & Co Verfahren zur herstellung einer antiviralen und antitumor-zusammensetzung, und deren verwendung
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
SE8505047L (sv) * 1985-10-25 1987-04-26 Nutritional Int Res Inst Fettemulsion
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
DE3903753A1 (de) * 1989-02-06 1990-08-23 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
NZ232865A (en) * 1989-03-21 1992-07-28 Hoffmann La Roche A mixed-micelle solution comprising a micelle former and an immunomodulator
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE3938030A1 (de) * 1989-11-13 1991-05-16 Schering Ag Verfahren zur herstellung waessriger mischmicelloesungen
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
CA2033714A1 (en) * 1990-01-25 1991-07-26 Alberto Ferro Pharmaceutical preparations
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
DE4122661C2 (de) * 1990-08-06 1996-07-11 Nattermann A & Cie Pharmazeutisches Produkt zur Behandlung von Pneumocystis-carinii-Pneumonie
ZA916314B (en) * 1990-08-17 1992-05-27 Hoffmann La Roche Use of mixed micelles
IL100874A (en) * 1991-02-08 1996-01-19 Pro Neuron Inc Oxiforin nucleosides and their composition, for use as medicines, their preparation and pharmaceutical preparations containing them
DE4336434A1 (de) * 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
GB9426104D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Use of surfactants and emulsions
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US6350738B1 (en) 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics
US6767904B2 (en) * 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
WO2002080883A2 (en) * 2001-03-27 2002-10-17 Phares Pharmaceutical Research N.V. Method and composition for solubilising a biologically active compound with low water solubility
WO2005095950A1 (en) * 2004-03-30 2005-10-13 Pfizer Products Inc. Method and device for evaluation of pharmaceutical compositions
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
DK2422789T3 (da) * 2004-05-19 2018-02-26 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Injicerbar sammensætning omfattende natriumdeoxycholat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
US8703204B2 (en) * 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008135852A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Pharmaceutical compositions comprising nanoparticles and casein
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008149192A2 (en) * 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2009010842A2 (en) * 2007-07-13 2009-01-22 Pfizer Products Inc. Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CN102058528B (zh) * 2009-11-13 2012-12-12 中国科学院上海药物研究所 一种黄豆苷元胶束及其制备方法
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
EP2675460A4 (en) 2011-02-18 2014-07-09 Kythera Biopharmaceuticals Inc TREATMENT OF FAT TISSUE UNDER CHIN
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
BR112014029188B1 (pt) * 2012-05-31 2020-02-11 Terumo Kabushiki Kaisha Veículo sensível ao ph e método de preparação do mesmo, e droga sensível ao ph e composição medicamentosa sensível ao ph contendo o veículo, e método de cultura usando o mesmo
US9321749B1 (en) 2012-07-25 2016-04-26 Globavir Biosciences, Inc. Heterocyclic compounds and uses thereof
AU2013370966A1 (en) 2012-12-24 2015-06-18 Neurogastrx, Inc. Methods for treating GI tract disorders
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
CN110876719B (zh) * 2018-09-06 2022-08-09 中国人民解放军军事科学院军事医学研究院 一种维生素k1注射剂及其制备方法
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE575616C (de) * 1928-12-14 1933-04-29 Hans Much Dr Verfahren zur Herstellung bestaendiger, klarer, waessriger Loesungen von Lipoiden, Fetten oder Harzen
DE932083C (de) * 1954-03-31 1955-08-22 Upha Chem Pharm Praeparate G M Verfahren zur Herstellung stabiler waessriger Injektionsloesungen von 2-Methyl-5, 8-dimethoxy-furanochromon
US3044931A (en) * 1960-01-27 1962-07-17 Geigy Chem Corp Aryloxy acetic acid amides: process for parenteral application
NL126750C (da) * 1960-12-05
US3639597A (en) * 1968-02-02 1972-02-01 Merck & Co Inc Pharmaceutical compositions containing cholanic acid conjugates
GB1317184A (en) * 1969-06-20 1973-05-16 Glaxo Lab Ltd Steroid-containing pharmaceutical preparations
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US4017616A (en) * 1972-01-21 1977-04-12 American Home Products Corporation Parenteral benzodiazepine compositions
AU461715B2 (en) * 1972-01-21 1975-05-19 American Home Products Corporation Parenteral benzodiazepine compositions
DE2315609A1 (de) * 1973-03-29 1974-10-17 Holzhueter Hermann Verfahren zum loesen von indomethacin in wasser und eine indomethacin enthaltende pharmazeutische zubereitung zur parenteralen applikation
DE2433173C3 (de) * 1974-07-10 1980-02-07 J. Pfrimmer & Co, 8520 Erlangen Verwendung von Cholansaurederivaten

Also Published As

Publication number Publication date
IL52458A (en) 1980-10-26
FR2358161B1 (da) 1980-07-25
FR2423219B1 (da) 1980-10-24
NL7707641A (nl) 1978-01-16
IE46037B1 (en) 1983-02-09
CA1082596A (en) 1980-07-29
NL189072C (nl) 1993-01-04
SE7708059L (sv) 1978-01-13
DE2730570C2 (da) 1989-01-19
SE448516B (sv) 1987-03-02
LU90037I2 (fr) 1997-06-13
NZ184564A (en) 1979-12-11
DK314777A (da) 1978-01-13
NL189072B (nl) 1992-08-03
JPS6051448B2 (ja) 1985-11-14
IE771403L (en) 1978-01-12
DK149483B (da) 1986-06-30
GB1587076A (en) 1981-03-25
IT1202370B (it) 1989-02-09
PH16333A (en) 1983-09-05
DK149483C (da) 1986-12-15
DE2730570A1 (de) 1978-01-19
IL52458A0 (en) 1977-10-31
MY8500263A (en) 1985-12-31
AU2684677A (en) 1979-01-11
FR2358161A1 (fr) 1978-02-10
AU517249B2 (en) 1981-07-16
JPS539314A (en) 1978-01-27
LU77708A1 (da) 1978-09-14
FR2423219A1 (fr) 1979-11-16
US4158707A (en) 1979-06-19

Similar Documents

Publication Publication Date Title
MY8500263A (en) Injection solutions containing micelle-forming agents
JPS5362392A (en) Liquid injector
JPS52134027A (en) Antiitumor agent
JPS5297900A (en) Padlock set
GB1557433A (en) Liquid cryogenpump
JPS5325525A (en) Radiooopaque agent
JPS5470433A (en) Antiiulcer agent
JPS52118497A (en) Antiiallergy agent
JPS5299230A (en) Antiitumor agent
JPS5297933A (en) Antiihypertensive agent
JPS5298932A (en) Liquid injection type battery
JPS535195A (en) Antiibacterial agent
JPS52117436A (en) Antiicoccidium agent
SU725543A3 (en) Insecticidic agent
JPS5386040A (en) Antiicoagulating agent
ZA775597B (en) Strengthening agents
JPS5331693A (en) Antiibacterial agents
ZA776821B (en) Antirhinovirus agents
JPS5372828A (en) Antiicancer agent
JPS52114025A (en) Antiitumor agent
JPS5297967A (en) Antiihypertensive agent
JPS5297963A (en) Antiihypertensive agent
JPS5379012A (en) Antiicancer agent
ZA776789B (en) Antirhinovirus agents
JPS52130932A (en) Antiisolidifying agent

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules